Regulus Therapeutics
RGLS
#8592
Rank
C$0.18 B
Marketcap
$2.85
Share price
6.19%
Change (1 day)
-6.25%
Change (1 year)

Regulus Therapeutics (RGLS) - Total debt

Total debt on the balance sheet as of December 2024 : C$0.37 Million

According to Regulus Therapeutics's latest financial reports the company's total debt is C$0.37 Million. A companyโ€™s total debt is the sum of all current and non-current debts.

Regulus Therapeutics - Total debt on balance sheet (from 2011 to 2024)

Total debt by year

Year Total debt Change
2024-12-31C$0.39 M-87.59%
2023-12-31C$3.16 M-62.81%
2022-12-31C$8.52 M-5.7%
2021-12-31C$9.03 M52.33%
2020-12-31C$5.93 M-68.96%
2019-12-31C$19.1 M-15.37%
2018-12-31C$22.57 M-9.57%
2017-12-31C$24.96 M-6.17%
2016-12-31C$26.61 M
2014-12-31C$27.15 M126.14%
2013-12-31C$12 M19.14%
2012-12-31C$10.07 M-0.93%
2011-12-31C$10.17 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
C$29.45 B 7,779,425.55%๐Ÿ‡ฌ๐Ÿ‡ง UK
C$25.74 B 6,800,374.45%๐Ÿ‡ซ๐Ÿ‡ท France
C$9.16 B 2,419,717.52%๐Ÿ‡บ๐Ÿ‡ธ USA
C$41.60 B 10,990,410.95%๐Ÿ‡ฌ๐Ÿ‡ง UK
C$1.79 B 472,910.95%๐Ÿ‡บ๐Ÿ‡ธ USA
C$42.23 M 11,055.47%๐Ÿ‡บ๐Ÿ‡ธ USA
C$70.73 B 18,686,031.39%๐Ÿ‡บ๐Ÿ‡ธ USA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA